Plasma and Intrapulmonary Concentrations Study of WCK 5222

Summary

This is a Phase 1, multiple dose, open-label pharmacokinetic study in healthy adult male and female subjects.

Timeline

Start

2017-03-31

Primary completion

2017-06-30

Completion

2017-07-30

Drugs

Indications